The Quality-Value Paradigm: The Global Expansion of Biosimilars
Biologics have revolutionized the treatment of complex diseases like cancer, rheumatoid arthritis, and Crohn's disease, but their high cost often limits patient access. Biosimilars are the pharmaceutical industry's answer to this challenge. A biosimilar is a biological product that is "highly similar" to an already approved "reference" biologic, with no clinically meaningful differences in...
0 Комментарии 0 Поделились 38 Просмотры 0 предпросмотр